CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities:
Net loss	$ (15,211,000)	$ (24,084,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	11,509,000	5,762,000
Change in fair value of financial instruments	(5,588,000)	3,900,000
Gain on initial investment in unconsolidated entity	(10,700,000)	0
Convertible debenture and other accrued interest	2,916,000	0
Asset impairment	0	1,822,000
Share-based compensation	1,646,000	2,686,000
Changes in right-of-use assets	1,453,000	1,877,000
Allowance for credit losses	1,187,000	(89,000)
Inventory provision	730,000	1,857,000
Other	1,594,000	(679,000)
Changes in operating assets and liabilities:
Accounts receivable, net	(1,151,000)	2,928,000
Inventories, net	3,593,000	112,000
Prepaid expenses and other current assets	(589,000)	3,086,000
Accounts payable, accrued and other liabilities	(328,000)	(4,238,000)
Operating lease obligations	(1,722,000)	(1,665,000)
License and media rights payable	(6,000,000)	0
Income taxes and other receivable	4,261,000	6,575,000
Other operating assets and liabilities, net	(449,000)	(2,449,000)
Net cash used in operating activities	(12,849,000)	(2,599,000)
Cash flows from investing activities:
Purchases of property and equipment and intangible assets	(3,015,000)	(411,000)
Proceeds from sale of assets	119,000	354,000
Net cash used in investing activities	(2,896,000)	(57,000)
Cash flows from financing activities:
Other financing activities	(202,000)	(325,000)
Net cash used in financing activities	(202,000)	(325,000)
Net decrease in cash and cash equivalents	(15,947,000)	(2,981,000)
Cash and cash equivalents —beginning of period	66,963,000	19,494,000
Cash and cash equivalents —end of period	51,016,000	16,513,000
Non-cash activities:
Non-cash purchase of property and equipment and intangible asset	(81,000)	0
Non-cash issuance of note receivable	$ (142,000)	$ 0